Byotrol Chinese Patent Approval



Byotrol plc (the "Company") is pleased to announce that a patent has been granted in China for its unique biocidal technology, its first for this country.

The patent has been granted around six months earlier than the Company had been forecasting and it will enable the Company to pursue a number of global opportunities it is currently working on, with the confidence that its products will enjoy patent protection within China.

The Company currently has a number of other patents pending in the Far East including Singapore and the granting of the Chinese patent follows successful applications in the UK and South Africa which were granted in 2005 and 2004 respectively. There are currently patents pending for the technology in numerous other countries including the USA, Europe, Canada and Australia and the Company expects these to be granted in due course.

The successful patent application follows the recent announcements of EPA approval in the USA and CE Mark approval in Europe and will enable sales of Byotrol technology in China to proceed under patent protection.

The Company is currently engaged in discussions with a number of global companies regarding deployment of Byotrol's technology and is pleased to able to announce it has secured significant contracts in the industrial and food processing sectors. The Directors consider these contracts demonstrate both the efficacy of Byotrol's technology and the ability of the management team to engage with major global organisations.

Becker Industrial Coatings, one of the world's leading industrial coatings manufacturers has launched a range of anti-microbial coatings containing Byotrol under the BeckryShield brand name. The launch follows extensive trials undertaken to test the efficacy of Byotrol's technology and the BeckryShield range offers effective anti-microbial protection for up to 2 years. The Company will receive revenues from the sale of concentrate and a royalty on sales achieved.

The Company has recently shipped its first customer order to Gold Kist, one of America's largest poultry processing companies, which is using Byotrol technology as part of its hygiene regime initially in its South Carolina processing plant.

- more -

Commenting on the successes, Byotrol Deputy Chairman Stephen Falder said:

"Securing the patent in China and winning significant contracts are the latest in a series of milestones for the Company. Importantly they are indicative of the consistent progress with product approvals and protection we are making as well as our ability to work successfully with major organisations. Based on work currently being undertaken and progress to date, the board is increasingly optimistic about future prospects for growth in our chosen market sectors."

- ends -

Financial calls to:

Stephen Falder 07767 404629

Deputy Chairman 0161 277 9518

Byotrol plc

David McRobbie  07739 549226

Chief Executive

Byotrol plc

Charles Stanley Securities 020 7149 6457

Philip Davies

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Just published

Young doctor

BMA poll could see 'demeaning' junior doctor title ditched

The BMA could drop the term 'junior doctor' in favour of 'resident doctor' to better...

Houses of parliament

Tory peer calls PA fears 'Luddism' and claims most GP visits 'incredibly straightforward'

Most GP appointments are 'incredibly straightforward' and fears over a wider role...

UK money

NHS pension contribution overhaul to go ahead from April

Changes to NHS pension contribution rates, which will see the top earners required...

BMA sign

BMA warns £800m lost from GP contract since 2019 as last-ditch talks continue

BMA negotiators remain in talks over an improved GP contract offer for 2024/25 just...

GP consultation

GPs still under pressure to prescribe black triangle drug inclisiran

GPs are continuing to face pressure to prescribe the black triangle drug inclisiran...

BMA chair Professor Phil Banfield

Lords urged to block legislation for GMC to regulate PAs

The BMA has urged peers to block legislation that would make the GMC responsible...